3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
36
Colorectal Neoplasms
17
Small Cell Lung Carcinoma
8
Neoplasms
8
Stomach Neoplasms
7
Neoplasm Metastasis
5
Sarcoma, Ewing
4
Rhabdomyosarcoma
4
Recurrence
4
Osteosarcoma
4
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Ovarian Neoplasms
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Solid Tumor
2
Neuroblastoma
2
Nasopharyngeal Carcinoma
2
Metastatic Pancreatic Adenocarcinoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Weight Loss
1
Somatostatinoma
1
Solid Tumor Cancer
1
Small Cell Lung Cancer Extensive Stage
1
Interventions
Paclitaxel
24
Hyperthermic Intraperitoneal Chemotherapy
24
Cisplatin
22
Oxaliplatin
17
Carboplatin
17
Fluorouracil
13
Cytoreduction Surgical Procedures
13
Bevacizumab
10
Mitomycin
9
Leucovorin
8
Doxorubicin
8
Docetaxel
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Surgical Procedures, Operative
4
Blood Specimen Collection
4
Albumin-Bound Paclitaxel
4
sodium thiosulfate
3
liposomal doxorubicin
3
catumaxomab
3
Taxes
3
Neoadjuvant Therapy
3
Laparoscopy
3
Drug Therapy
3
tremelimumab
2
relacorilant
2
pembrolizumab
2
olaparib
2
nintedanib
2
epothilone B
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Peritoneal Neoplasms
×
irinotecan sucrosofate
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled